ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 41874881

Recent Advances in Targeted Therapies for Adult Gliomas.

Lasica AB and 4 others. Curr Neurol Neurosci Rep, 2026. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Recent Advances in Targeted Therapies for Adult Gliomas. Papers, record 41874881. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41874881

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent Advances in Targeted Therapies for Adult Gliomas.
PubMed
Journal
Curr Neurol Neurosci Rep
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lasica ABAleksandra B
2Tang ARAlice R
3Iqbal AArooba
4Nakhate VVihang
5Wen PYPatrick Y

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GliomaMajor topic
Brain NeoplasmsMajor topic
Molecular Targeted TherapyMajor topic
Antineoplastic AgentsMajor topic
Humans
Adult

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References126

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118,772,396An integrated genomic analysis of human glioblastoma multiforme.Science2008https://conductscience.org/library/papers/18772396PubMed
237,541,273Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.Lancet Oncol2023https://conductscience.org/library/papers/37541273PubMed
319,665,931Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.Lancet Neurol2009https://conductscience.org/library/papers/19665931PubMed
437,777,119Ocular toxicities of fibroblast growth factor receptor inhibitors: A review.Surv Ophthalmol2024https://conductscience.org/library/papers/37777119PubMed
537,770,109[123I]CC1: A PARP-Targeting, Auger Electron-Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer.J Nucl Med2023https://conductscience.org/library/papers/37770109PubMed
638,446,982Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma.Clin Cancer Res2024https://conductscience.org/library/papers/38446982PubMed
737,733,309Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations.N Engl J Med2023https://conductscience.org/library/papers/37733309PubMed
829,594,237
PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status.
Clin Transl Radiat Oncol2018https://conductscience.org/library/papers/29594237PubMed
940,241,139Application of EGFR-TKIs in brain tumors, a breakthrough in future?J Transl Med2025https://conductscience.org/library/papers/40241139PubMed
1031,747,009INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma.Neuro Oncol2020https://conductscience.org/library/papers/31747009PubMed

1 to 10 of 126

See all 126 references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42,863,764The current landscape of neuro-oncology clinical trials.Clin Med (Lond)2026https://conductscience.org/library/papers/42863764PubMed
42,373,227Upregulated CircRNAs With Efficacy in Preclinical In Vivo Models Reveal New Targets for Therapeutic Intervention in Glioma.Cancer Genomics Proteomics2026https://conductscience.org/library/papers/42373227PubMed

Genes52

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ATF4468PubTator's text mininghttps://conductscience.org/library/genes/468NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
ATR545PubTator's text mininghttps://conductscience.org/library/genes/545NCBI Gene
ATRX546PubTator's text mininghttps://conductscience.org/library/genes/546NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CD27680,381PubTator's text mininghttps://conductscience.org/library/genes/80381NCBI Gene
CIC23,152PubTator's text mininghttps://conductscience.org/library/genes/23152NCBI Gene
DDIT31,649PubTator's text mininghttps://conductscience.org/library/genes/1649NCBI Gene

1 to 10 of 52

See all 52 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41874881

GET https://conductscience.org/api/papers/v1/41874881/references?page=2

API referenceFor AI assistants